Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells

Immunology

Volumn 105, Issue 1, 2002, Pages 83-91

  Jeong, Jae Yeon ^a   Choi, Jae Won ^a   Jeon, Kye Im ^a   Jue, Dae Myung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMMONIUM CHLORIDE; BB 3103; CHLOROQUINE; HYDROXYCHLOROQUINE; LEUPEPTIN; MESSENGER RNA; METALLOPROTEINASE INHIBITOR; METHYLAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P55; PROTEIN P75; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL DIVISION; CELL LEVEL; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; HISTIOCYTOSIS; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS;

ANTIRHEUMATIC AGENTS; BLOTTING, NORTHERN; CHLOROQUINE; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTIOCYTOSIS; HUMANS; HYDROXAMIC ACIDS; LEUKOCYTES, MONONUCLEAR; PROTEASE INHIBITORS; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0036162115     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0019-2805.2001.01339.x     Document Type: Article

References (40)

1. Tumor necrosis factors: Developments during the last decade
2. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
3. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
4. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease
5. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
6. Tumor necrosis factor identified in multiple sclerosis brain
7. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein
8. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
9. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κB. TNFα is not needed for induction of a biological effect via TNF receptors
10. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
11. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
12. Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. Comparison with another tumor promoter, phorbol ester
13. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells
14. TNF induces internalization of the p60 receptor and shedding of the p80 receptor
15. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
16. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes
17. An essential role for ectodomain shedding in mammalian development
18. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses
19. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA Study
20. Anti-malarials in dermatology
21. Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release
22. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism
23. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-α, interleukin 6, and interferon-γ production by peripheral blood mononuclear cells
24. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages
25. Production of tumor necrosis factor α in human leukocytes stimulated by Cryptococcus neoformans
26. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
27. Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins
28. The complete sequence of a full length cDNA for human liver glyceraldehyde 3-phosphate dehydrogenase: Evidence for multiple mRNA species
29. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures
30. Perturbation of vesicular traffic with the carboxylic ionophore monensin
31. The advantage of being uncompetitive
32. Inhibitors of lysosomal function
33. Mannose-specific endocytosis receptor of alveolar macrophages: Demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling
34. Lysomotropic amines cause intracellular accumulation of receptors for epidermal growth factor
35. Involvement of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor
36. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes
37. Analysis of the effect of amines on inhibition of receptor-mediated and fluid-phase pinocytosis in rabbit alveolar macrophages
38. Ammonia inhibits protein secretion in isolated rat hepatocytes
39. +-ATPases in the secretory pathway of HepG2 cells
40. Pharmacologic actions of 4-aminoquinoline compounds